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ABSTRACT
Objective: This study observed the antibacterial, antifungal (aquatic and pathogenic fungi), and anthelmintic properties of Lactobacillus plantarum 
(LP) KP894100 and Lactobacillus acidophilus (LC) KP942831, isolated from a dairy product.
Methods: Lactic acid bacteria traditionally used to improve human health. For in vitro antibacterial, antifungal, and antihelminthic studies of 
intracellular cell-free extract (ICFE) from LP and LC were produced separately by using filtration methods. ICFE was freeze-dried then resuspended 
in citrate phosphate buffer. This ICFE is further used for the antimicrobial and anthelmintic assay. In the antimicrobial assay, ICFE were tested against 
pathogenic bacteria, i.e., Bacillus subtilis, Escherichia coli, Enterococcus faecalis, Staphylococcus aureus, Staphylococcus epidermidis, Pseudomonas 
stutzeri, Pseudomonas aeruginosa, and aquatic fungal species including: Aspergillus clavatus, Pythium aphanidermatum Saprolegnia parasitica, 
Candida albicans, Aspergillus fumigatus, Fusarium oxysporum, Alternaria alternata, Curvularia sp., Mucor sp., Rhizopus stolonifer, Aspergillus niger, and 
Penicillium chrysogenum. In the anthelmintic assay, young stages of Pheretima posthuma (Indian earthworms) were used. For the analysis of acute 
toxicity assay different graded doses (100, 250, 500, 1000 mg/kg bw) of ICFE of LP and LC was administered in Wistar albino rats, respectively, and 
the control group received distilled water.
Result: The ICFE of both Lactobacillus strains showing strong antibacterial and weak antifungal activity against aquatic fungi except, S. parasitica, and 
C. albicans. The ICFE shows 100% paralysis and killing efficacy against P. posthuma in 48-72 hrs. In the acute toxicity test, LP and LC did not produce 
any toxic signs or death at the maximum concentration 1000 mg/kg bw.
Conclusion: ICFE of LP and LC possess anthelmintic activity against P. posthuma with only strong antibacterial activity. Both the lactobacillus strains 
have strong antibacterial activity and have potential activity against P. posthuma helminthes.
Keywords: Antimicrobial, Antifungal, Aquatic fungi, Anthelmintic activity, Pheretima posthuma.
INTRODUCTION
Contagious and parasitic infections continue to be a considerable 
burden in developing countries. Helminth infections are the most 
common infections in humans, distressing an enormous population 
of the world. Helminthiasis is the most important animal diseases 
inflicting heavy production losses. Chemical control of helminth 
infection coupled with improved management has been the important 
worm control strategy throughout the world [1]. However, the majority 
of parasitic infections is mostly limited to tropical regions and causes 
a huge threat to human health and contributes to the occurrence 
of malnutrition, anemia, eosinophilia, and pneumonia [2]. Parasitic 
diseases cause ruthless morbidity affecting the principal population 
in endemic areas [3]. The gastrointestinal (GI) helminths become 
resistant to currently available anthelmintic drugs; therefore, there is a 
foremost problem in the treatment of helminth diseases [4]. However, 
increasing problems of development of resistance in helminths against 
drug have led to the proposal of screening labor, natural products for 
their anthelmintic activity which are safe for human as well as animal.
The validation of the antibiotic properties of lactic acid bacteria (LAB) 
is greatly needed because the development of new drugs from these 
bacteria will complement the decreasing arsenal of potent antibiotic 
and antiparasitic agents currently available. Nowadays, probiotic 
bacteria are most commonly used as an alternative to antibiotics [5]. 
Using of probiotic bacteria, the chance of drug resistance may decrease. 
In addition, LAB with health promoting activity is willingly accessible 
for human use and once their scientific validation and efficacy are 
known the value of these bacteria need no longer be based on folkloric 
recommendations. Therefore, the objective of this work was to explore 
the anthelmintic and antimicrobial properties of LAB. Previously, 
no paper reported the effect of LAB on aquatic fungi and helminths 
Pheretima posthuma.
The LAB are conventionally used to improve immune system also used 
in pharmaceutical as an alternative of antibiotic [6], antimicrobial [7], 
anticancer [8], antidiabetic [9], Immunomodulatory [10], lactose 
intolerance, as well as bio preservatives in food [11,12], and 
improvement of gut microflora or to manage gut related problems [13]. 
Certainly, in a recent study, the intracellular cell-free extract (ICFE) 
from LAB showed in vivo antiproliferation of cancer, antimutagenic and 
anticarcinogenic activity [14]. Since LAB was safe recognized by WHO 
and FDA in 1990 [15], at the present increasing use of this bacteria as 
living medicine [16-18]. Since few studies so far exist on the biological 
activity of these bacteria to the best of our knowledge. The study 
reported here focuses on the in vivo acute toxicity of ICFE of LAB as well 
as its efficacy as an antimicrobial and anthelminthic agent.
METHODS
Bacterial culture
220 Lactobacillus strains have been isolated from milk and different 
dairy products commercially available in the local markets such as 
cheese, yogurt, and curd. The isolation was performed by the routine 
microbiological procedure and inoculation on MRS broth [19]. The 
isolated colonies will be screened for antimicrobial potential against 
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Escherichia coli; those bacterial colonies give the highest inhibition 
zone will be further identified by 16S rRNA sequence analysis. The 
sequence of the organisms was deposited in the GenBank nucleotide 
sequence databases under accession number KP894100, KP942831 
for Lactobacillus plantarum (LP) and Lactobacillus acidophilus (LC), 
respectively.
Preparation of ICFE of LP and LC
For antimicrobial activity, preparations of ICFE are done according to 
the method is given by Chiu et al. (2013) with slight modification [20]. 
800 ml of MRS broth contains cultures of LP and LC was harvested 
by centrifugation (10,000 g, 30 minutes, and 4°C) and washed twice 
with phosphate buffered saline, total cell numbers were adjusted to 
108 CFU/ml, respectively. Pressure Cells Press (Thermo Electron) was 
used for cell disruption, then centrifuged at 10,000 g for 15 minutes, 
and the supernatant was filtered through syringe filters (0.45 mm pore 
size; Millipore). The sterile cell-free supernatant (CFS) was freeze-
dried and resuspended (to a 15-fold concentration) in 20 mM citrate 
phosphate buffer (pH 3.4). This ICFE is used for further different assays.
Acute toxicity
For acute toxicity testing in animals, preparation was carried out 
according to the standard method is given by Zhou et al. [21] and Wolf et 
al. [22]. Wistar rats of either sex (weighing 125-150 g) were purchased 
from the Department of Research and Defence Establishment, 
Gwalior. The animals were maintained in a well-ventilated room, fed 
on commercial balanced pellet feed, and water ad libitum. Prior to 
acute toxicity evaluation, the animals were acclimatized to standard 
conditions of temperature, moisture, aeration, and nutrition in the 
animal house of the Department of Pharmaceutical Sciences, Dr. Hari 
Singh Gour University. All studies on animals were approved by the 
Institutional Animal Ethics Committee (IAEC, DHSGU Sagar) with 
sanction number CPSEAE-48/13.
The Wistar rats were divided into 5 groups; each group contains 6 rats. 
Group 1 serves as a control; the rest is treated by oral administration of 
graded doses 100, 250, 500, 1000 mg/kg bw of ICFE for 7 days.
Antimicrobial activity
Pathogenic bacterial and aquatic fungal strain; culture media
The bacterial strains used in this study included as representative 
of Gram-positive bacteria Lactobacillus viridescens NCIM 2167, 
Lactobacillus jugurti NCIM 2367, Lactobacillus pentosus NCIM 
2669, Bacillus subtilis, MTCC 1143, Enterococcus faecalis MTCC 
439, Staphylococcus aureus MTCC 9886 and Pseudomonas stutzeri 
MTCC 8350, Pseudomonas aeruginosa MTCC 6642, E. coli MTCC 433, 
Proteus vulgaris, Staphylococcus epidermidis MTCC 7919, Salmonella 
Typhimurium, Vibrio cholera MTCC 3906, Klebsiella pneumonia was 
used as representative of Gram-negative strains.
The pathogenic aquatic fungus culture is Aspergillus clavatus 
MTCC1323, Candida albicans MTCC 7315, Pythium aphanidermatum 
MTCC 10247, Saprolegnia parasitica MTCC718, were procured 
from microbial culture collection center (MTCC) Chandigarh, India. 
Alternaria alternate, Aspergillus niger, Aspergillus fumigatus, Curvularia 
sp., Fusarium oxysporum, Mucor sp., Penicillium chrysogenum, Rhizopus 
stolonifer, is represented as pathogenic fungi collected from the culture 
collection center of the department of botany, Dr. H.S. Gour University, 
Sagar, India. The preparation of bacterial strain and fungal spore 
for antibacterial activity was done according to the method given by 
Hladikova et al. [23].
Antimicrobial assay
The disk diffusion method was used for antimicrobial assay according 
to the method given by Oliveira et al. [24]. Briefly, indicator bacteria 
were grown in Muller-Hinton broth (HiMedia, India) overnight and 
spread onto the soft agar (1%, w/v) plate of MH Agar after diluting to 
107 CFU/ml, Subsequently, 50 µl samples prepared from filtrate was 
absorbed by sterile disc these discs transferred to MHA plates then 
incubated at 37°C for 24 hrs, the inhibitory activity was determined by 
measuring the radius of inhibition zone around the disc in mm. MRS 
broth adjusted at pH 6.5 served as control. All the assays were carried 
out in triplicate. Gentamycin and streptomycin were used as positive 
control.
Antifungal assay
The LAB was screened for antifungal activity by disk diffusion 
assay as described by Magnusson and Schnurer, 2006 with slight 
modification [25]. Briefly, the MRS agar plates containing 104 spores/ml 
agar were prepared. Sterile disk with 50 µl of ICFE was put on the MRS 
agar plate allowed to diffuse into the agar during a 5 hrs pre-incubation 
period at room temperature, followed by aerobic incubation at 30°C for 
48 hrs. The antifungal effects recorded were as clear zones around the 
disk; Standard drug Nystatin, griseofulvin is used as positive control.
Anthelmintic assay
Anthelmintic activity was carried out according to the method 
suggested by Ahirwal et al. (2010) with slight modifications [26]. Indian 
young earthworms (P. Posthuma) collected from the moist soil of the 
vermin farm Sagar (MP), India and washed with normal saline and 
used for the study. The ICFE of both bacteria were dissolved in 20 mm 
citrate phosphate buffer and prepared desired concentrations (100, 
250,500, and 1000 mg/ml). Piperazine citrate (20 mg/ml) was used 
as the standard drug. All the samples, standard drug and 4 different 
concentrations of the ICFE were freshly prepared before starting the 
experiment. 14 groups containing 6 earthworms in each group were 
placed into 15 ml of ICFE concentration. Group 1 served as control 
being treated with 20 mm citrate phosphate buffer (control group) 
while Group II was treated with the standard drug (Piperazine citrate) 
20 mg/ml and 2 sets of 5 different groups were treated with extracts 
of respective concentrations. Observations were made for the time 
taken for paralysis and death of individual worm. The paralysis was 
said to occur when the worms were not able to move even in normal 
saline while the death was concluded when the worms lost their 
motility followed with fading away their body colors [27]. Assays were 
conducted in duplicate.
Statistical analysis
Data were expressed as the mean, standard deviation of the means 
and statistical analysis were carried out employing one-way ANOVA. 
Differences between the data were considered significant at p<0.05. 
For the anthelmintic assay, each experiment was run in duplicate and 
the mean calculated using Excel software.
RESULTS
Acute toxicity studies
There was no mortality in the treatment and control groups after 24 
hrs of ICFE administration. None of the rats died during the 7 days of 
observation. No adverse effects were noticed in the behavior of the 
rats in any of the treatment or control groups. There was no drop in 
body weight in any of the groups as well. A physical examination prior 
to euthanasia on the 7th day showed that the rats looked healthy with 
no ruffled hair or any abnormality in the body. Organ examination did 
not reveal any abnormalities or gross lesions. Acute toxicity studies of 
ICFE of LAB have been extensively carried out and found non-toxic at 
concentrations as high as 1000 mg/kg body weight of animals.
Antibacterial spectrum
To evaluate the antibacterial activity of the ICFE of LP and LC, the 
pathogenic bacterial strains were exposed to the 50 µl of ICFE. Both 
the tested ICFE showed different bioactivities at 50 µl of concentration. 
Remarkably, the ICFE of LP showed the highest degree of activity against 
all microbial strains (Figs. 1 and 2). Furthermore, both ICFE showed the 
highest antibacterial activity against S. Typhimurium.
Antifungal assay
The disk diffusion method was used to detect the antifungal spectrum 
of ICFE of LP KP894100 and LC KP942831 against toxin producing 
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fungi (Aspergillus spp., Penicillium spp., Fusarium spp.), human disease-
causing aquatic fungi (C. albicans) and food spoilage fungi (Penicillium 
spp., Fusarium spp.) were determined by disk diffusion assay. ICFE of 
LP had a broad antifungal inhibitory spectrum, against 2 aquatic fungi, 
i.e., S. parasitica and C. albicans. The inhibitory effects of ICFE on the 
growth of different fungal strains are presented in Figs. 3 and 4. Both 
Lactobacillus strains restricted the germination of fungal spore of most 
of the fungal strains. However, great variation in growth inhibition was 
observed between different fungi, some fungi being more resistant to 
the antimicrobial substances produced by these lactobacilli. However, 
the fast-growing Ascomycetes A. niger was only marginally affected. 
The antifungal activity differed only slightly between incubation 
temperature at 25 or 30°C. In particular, the C. albicans, S. parasitica, 
and A. niger were insensitive to ICFE. The LAB strains were also effective 
against Rhizopus, Mucor, Curvularia strains. Although the strains of 
lactobacillus are isolated from different sources had surprisingly 
similar antifungal spectra.
Anthelmintic assay
The anthelmintic activity of ICFE was assessed on the soil nematode 
P. posthuma. Anthelmintic activity was observed against the young stage 
of P. Posthuma mostly during 48-72 hrs post-treatment (Fig. 5), while 
both the ICFE from LAB demonstrated potent anthelmintic activity, 
killing 100% of the young worms at 100 mg/ml in 48-72 hrs (Fig. 6). 
From the observations made, a higher concentration of ICFE produced 
a paralytic effect much earlier and the time of death was shorter for 
all worms. ICFE showed anthelmintic activity in a dose-dependent 
manner, giving the shortest time of paralysis (P) and death (D) with 
500 mg/ml concentration, for all young worms. ICFE exhibited more 
potent activity at higher concentration (1000 mg/ml). Evaluation of 
anthelmintic activity was compared with reference standard Piperazine 
citrate (Fig. 5).
DISCUSSION
The selection of an appropriate method for the ICFE production is 
fundamental to initial successful prediction of the biological activity 
of LAB. Based on the activity observed, the efficacy of the general 
preparations of ICFE might be enhanced by the use of different 
purification techniques such as purified by reversed phase-high-
performance liquid chromatography. The LAB are traditionally used 
without extraction of ICFE and have the possibility of giving different 
results compared to ICFE. Unfortunately, the effect of the LAB when 
Fig. 1: Growth inhibition (zone of inhibition) of pathogenic 
bacteria by intracellular cell-free extracts of Lactobacillus 
plantarum as measured by disk diffusion methods. Streptomycin 
and Gentamycin are used as standard drugs. The results are 
means±standard deviation of triplicates, p≤0.05
Fig. 2: Growth inhibition (Zone of inhibition) of pathogenic 
bacteria by intracellular cell-free extracts of Lactobacillus 
acidophilus as measured by disk diffusion methods. Streptomycin 
and gentamycin are used as standard drugs. The results are 
means±standard deviation of triplicates, p≤0.05
Fig. 3: Growth inhibition (zone of inhibition) of fungi by 
intracellular cell-free extracts of Lactobacillus plantarum as 
measured by disk diffusion methods. Nystatin and Griseofulvin 
are used as standard drugs. The results are means±standard 
deviation of triplicates, p≤0.05
Fig. 4: Growth inhibition (zone of inhibition) of fungi by 
intracellular cell-free extracts of Lactobacillus acidophilus as 
measured by disk diffusion methods. Nystatin and Griseofulvin 
are used as standard drugs. The results are means±standard 
deviation of triplicates, p≤0.05
Fig. 5: Anthelminthic activity of intracellular cell-free extract of 
Lactobacillus plantarum and Lactobacillus acidophilus, Piperazine 
citrate used as standard drug. The results are means±standard 
deviation of triplicates, p≤0.05
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consumed directly can only be measured properly in an in vivo 
model. Nevertheless, Lactobacillus sp. Least reported in the literature 
against different disorders prevalent in the human population; hence, 
assessment of toxic effects of ICFE from both the bacteria were essential 
in our study too. Finally, 4 doses of each ICFE were chosen on the basis 
of acute toxicity studies for anthelmintic activity.
The antibacterial activity indicates that ICFE of LP possesses strong 
activity against the microorganisms as compared to ICFE of LC (Figs. 1 
and 2); However, the ICFE of LC showed moderate activity against 
the fungus S. parasitica (10.35±0.21) and C. albicans (12.32±0.44) 
(Fig. 4). The antibacterial activity of LC observed against S. aureus 
(Fig. 2). Compared to the observed by Oh et al. (2000), the CFS of LC 
30SC have the potential to inhibit some gram-positive pathogenic 
bacteria including Bacillus cereus ATCC 11778, Listeria ivanovii, and 
S. aureus [28]. The ICFE may have potential use as a food additive in 
the food industry, particularly processed food, in which some Bacillus 
species are potential spoilage microorganisms.
The young earthworms (2-4 cm in length and 0.1-0.2 cm in width) were 
used for all the experimental protocols due to their anatomical and 
physiological resemblance with the intestinal roundworm parasites 
of human beings. More than one billion people are infected worldwide 
annually by soil-transmitted helminths, which are parasitic intestinal 
nematodes [29-31]. The validation of anthelmintic activity of LAB is a 
great necessity as this could lead to recommendations for the improved 
use of LAB as well as provide opportunities for the discovery of new 
anthelmintic drugs. In this study, there was good antiparasitic activity 
was recorded against the young stage of the nematode P. posthuma. The 
ICFE of LP and LC demonstrated the best activity killing 100% of the 
young worms within 72 hrs at 1000 mg/ml (Fig. 5). Further studies to 
identify the active antiparasitic compound(s) in ICFE, as well as activity 
against other helminths is recommended. There is no study reported on 
the anthelmintic effect of LAB while traditionally many plant parts are 
used as anthelmintic drugs [32-34].
The LAB did not produce mortality in rats at the highest CFU tested. 
Attempts to escalate the dose failed due to the fact that 108 cfu/ml was 
the maximum amount that was able to maintain healthy gut intestinal 
health. Despite the fact that no adverse effects were observed, it is 
recommended that a chronic toxicity study be done in the future to 
confirm the safety of this product for long term usage. Even though LAB 
is used as probiotic drugs for the treatment of many disorders in some 
developing countries where access to modern health facilities is limited, 
generally very little is known about their toxicity and this applies also to 
LAB. Despite the fact that efficacy is one of the overriding criteria in the 
selection of LAB for use in healthcare systems, safety should never be 
overlooked, and formal toxicological evaluation of LAB should be done 
as part of the validation process.
From the above results, it is concluded that the presence of LAB in dairy 
products, traditionally used by humans to improve intestinal health, 
showed significant anthelmintic activity. The experimental evidence 
obtained in the laboratory model could provide a rationale for the 
traditional use of this LAB as anthelmintic. The ICFE may be further 
explored for its biochemical profile to recognize the active constituent 
accountable for anthelmintic activity.
CONCLUSION
This study exhibited an anthelmintic as well as a strong antibacterial 
and weak antifungal activity of 2 lactobacillus species, i.e., LP and LC. 
There is no-observed adverse-effect of the bacteria in the acute toxicity 
study in rats at the highest concentration of ICFE. Both the bacteria are 
safe for long-term treatments considering the live bacteria at which no 
toxicity is detected, the anthelmintic dose may, in fact, be reached in 
the GI-tract and thus give support to the traditional use of LAB as living 
medicine to control worms. On the other hand, the strong antibacterial 
activity founds in ICFE confirm that its use in the treatment of infectious 
diseases is causing by pathogenic bacteria.
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